Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability

• 收藏
• 分享

专利权人:

Kyoto University;Astellas Pharma Inc.

发明人:

HARA, Hideaki,NARUMIYA, Shuh,AOKI, Tomohiro,ARAMORI, Ichiro,YAMAMOTO, Rie

申请号：

AU2019214265

公开号：

AU2019214265A1

申请日:

2019.02.01

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Provided is a medicine for preventing or treating an ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability. The present inventors have made studies on medicines for preventing or treating ophthalmic diseases associated with enhanced intraocular neovascularization and/or intraocular vascular permeability. As a result, it is confirmed that a selective S1P receptor agonist having an agonistic activity on a S1P

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/